Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.
Angelats L, Paré L, Rubio-Perez C, Sanfeliu E, González A, Seguí E, Villacampa G, Marín-Aguilera M, Pernas S, Conte B, Albarrán-Fernández V, Martínez-Sáez O, Aguirre Á, Galván P, Fernandez-Martinez A, Cobo S, Rey M, Martínez-Romero A, Walbaum B, Schettini F, Vidal M, Buckingham W, Muñoz M, Adamo B, Agrawal Y, Guedan S, Pascual T, Agudo J, Grzelak M, Borcherding N, Heyn H, Vivancos A, Parker JS, Villagrasa P, Perou CM, Prat A, Brasó-Maristany F. Angelats L, et al. Among authors: albarran fernandez v. ESMO Open. 2025 Jan 6;10(1):104109. doi: 10.1016/j.esmoop.2024.104109. Online ahead of print. ESMO Open. 2025. PMID: 39765189 Free article.
Biomarkers for response to TIL therapy: a comprehensive review.
Albarrán Fernández V, Ballestín Martínez P, Stoltenborg Granhøj J, Borch TH, Donia M, Marie Svane I. Albarrán Fernández V, et al. J Immunother Cancer. 2024 Mar 13;12(3):e008640. doi: 10.1136/jitc-2023-008640. J Immunother Cancer. 2024. PMID: 38485186 Free PMC article. Review.
Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.
San-Román-Gil M, Martínez-Delfrade I, Albarrán-Fernández V, Guerrero-Serrano P, Pozas-Pérez J, Chamorro-Pérez J, Rosero-Rodríguez D, Sotoca-Rubio P, Barrill-Corpa AM, Alia-Navarro V, González-Merino C, García-de-Quevedo-Suero C, López V, Ruz-Caracuel I, Perna-Monroy C, Ferreiro-Monteagudo R. San-Román-Gil M, et al. Among authors: albarran fernandez v. Front Immunol. 2024 Feb 1;15:1352262. doi: 10.3389/fimmu.2024.1352262. eCollection 2024. Front Immunol. 2024. PMID: 38361927 Free PMC article. Review.
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma.
San-Román-Gil M, Torres-Jiménez J, Pozas J, Esteban-Villarrubia J, Albarrán-Fernández V, Álvarez-Ballesteros P, Chamorro-Pérez J, Rosero-Rodríguez D, Orejana-Martín I, Martínez-Delfrade Í, Reguera-Puertas P, Fuentes-Mateos R, Ferreiro-Monteagudo R. San-Román-Gil M, et al. Among authors: albarran fernandez v. Cancers (Basel). 2023 Jan 30;15(3):863. doi: 10.3390/cancers15030863. Cancers (Basel). 2023. PMID: 36765821 Free PMC article. Review.
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J, Albarrán-Fernández V, González-Campo L, Olmedo-García ME, Corral de la Fuente E, Corral-Corral I, Carrasco Á, Alonso-Gordoa T, Molina-Cerrillo J, Lage-Alfranca Y, Gómez-Rueda A, Garrido P. Pozas J, et al. Among authors: albarran fernandez v. Transl Lung Cancer Res. 2022 Jul;11(7):1497-1502. doi: 10.21037/tlcr-21-989. Transl Lung Cancer Res. 2022. PMID: 35958343 Free PMC article.
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Torres-Jiménez J, Albarrán-Fernández V, Pozas J, Román-Gil MS, Esteban-Villarrubia J, Carrato A, Rosero A, Grande E, Alonso-Gordoa T, Molina-Cerrillo J. Torres-Jiménez J, et al. Among authors: albarran fernandez v. Int J Mol Sci. 2021 Jan 13;22(2):747. doi: 10.3390/ijms22020747. Int J Mol Sci. 2021. PMID: 33451055 Free PMC article. Review.